Hematological Manifestations in Systemic Lupus Erythematosus Patients

Patan Academy of Health Sciences

Status: Completed

Conditions: Systemic Lupus Erythematosus (SLE)

Study type: Observational

Funder types: Other

Identifiers

NCT06936007

drs2412171972

Details and patient eligibility

About

The goal of this observational study is to evaluate hematological abnormalities among patients with systemic lupus erythematosus (SLE) admitted to a tertiary care center in Nepal. The main question it aims to answer is:

• What are the types and frequencies of hematological abnormalities seen in hospitalized SLE patients in Nepal?

The study retrospectively reviews medical records of SLE patients admitted between April 2018 and March 2023 to collect data on hematologic parameters, demographic profiles, clinical manifestations.

Enrollment: 99 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• All the patient diagnosed with systemic lupus erythematosus based on 2019 European League of Associations for Rheumatology and American College of Rheumatology (2019 EULAR/ACR) criteria.

Exclusion criteria

• Underlying hematological diseases or conditions: Patients who had hematological disease (e.g. hemophilia, leukemia, lymphoma) or conditions that could independently affect hematological parameters.
• Incomplete records

Trial design

99 participants in 1 patient group

Systemic Lupus Erythematosus Patients

Description:

Patients diagnosed with systemic lupus erythematosus as per 2019 European League of Associations for Rheumatology and American College of Rheumatology (2019 EULAR/ACR) criteria